• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Disparities in cervical cancer elimination time frames in the United States: a comparative modeling study.美国宫颈癌消除时间框架的差异:一项比较建模研究
J Natl Cancer Inst. 2025 Jul 1;117(7):1498-1502. doi: 10.1093/jnci/djae319.
2
State-level disparities in cervical cancer prevention and outcomes in the United States: a modeling study.美国宫颈癌预防与治疗结果的州级差异:一项建模研究。
J Natl Cancer Inst. 2025 Apr 1;117(4):737-746. doi: 10.1093/jnci/djae298.
3
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
4
A scoping review of human papillomavirus related data system in China.中国人类乳头瘤病毒相关数据系统的范围综述。
BMC Infect Dis. 2025 Jul 1;25(1):873. doi: 10.1186/s12879-025-11106-y.
5
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
6
Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK.英国治疗高级别宫颈上皮内瘤变患者的九价 HPV 疫苗接种的成本效益分析。
JAMA Netw Open. 2024 Oct 1;7(10):e2437703. doi: 10.1001/jamanetworkopen.2024.37703.
7
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
8
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
9
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
10
Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.将人乳头瘤病毒(HPV)疫苗接种计划与强化宫颈癌筛查及治疗相结合:一项系统评价
Vaccine. 2022 Mar 31;40 Suppl 1:A116-A123. doi: 10.1016/j.vaccine.2021.11.013. Epub 2021 Dec 1.

引用本文的文献

1
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.安全网环境下宫颈癌筛查的自我采样:PRESTIS随机临床试验
JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2971.

本文引用的文献

1
Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study.快速消除宫颈癌,同时保持宫颈癌筛查的危害与效益比:建模研究。
BMC Med. 2022 Nov 9;20(1):433. doi: 10.1186/s12916-022-02631-7.
2
Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006-2016.2006-2016 年,美国一项全国性私人保险年轻女性队列研究显示,宫颈癌筛查因 HPV 疫苗接种状态而异。
Medicine (Baltimore). 2021 Oct 15;100(41):e27457. doi: 10.1097/MD.0000000000027457.
3
Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US.美国未接种人乳头瘤病毒疫苗女性的宫颈癌筛查参与度和依从性评估。
JAMA Netw Open. 2021 Oct 1;4(10):e2131129. doi: 10.1001/jamanetworkopen.2021.31129.
4
Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.减少宫颈癌相关的贫困差距:HPV 疫苗接种的作用。
Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1895-1903. doi: 10.1158/1055-9965.EPI-21-0307. Epub 2021 Sep 9.
5
Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations.人乳头瘤病毒联合检测后宫颈癌筛查的临床随诊实践:一项基于人群的美国指南推荐依从性研究。
Prev Med. 2021 Dec;153:106770. doi: 10.1016/j.ypmed.2021.106770. Epub 2021 Aug 18.
6
Projected time to elimination of cervical cancer in the USA: a comparative modelling study.美国消除宫颈癌的预计时间:一项比较建模研究。
Lancet Public Health. 2020 Apr;5(4):e213-e222. doi: 10.1016/S2468-2667(20)30006-2. Epub 2020 Feb 10.
7
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.使用仿真模型估计宫颈癌的自然史:CISNET 比较分析。
J Natl Cancer Inst. 2020 Sep 1;112(9):955-963. doi: 10.1093/jnci/djz227.
8
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.宫颈癌筛查:美国预防服务工作组推荐声明。
JAMA. 2018 Aug 21;320(7):674-686. doi: 10.1001/jama.2018.10897.
9
A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review.将健康公平的当代框架应用于妇科癌症护理:妇科肿瘤学协会基于证据的审查。
Gynecol Oncol. 2018 Apr;149(1):70-77. doi: 10.1016/j.ygyno.2017.11.013.
10
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting.接受人乳头瘤病毒(HPV)和细胞学联合检测的女性对延长宫颈筛查间隔的依从模式。
Prev Med. 2018 Apr;109:44-50. doi: 10.1016/j.ypmed.2017.12.023. Epub 2017 Dec 27.

美国宫颈癌消除时间框架的差异:一项比较建模研究

Disparities in cervical cancer elimination time frames in the United States: a comparative modeling study.

作者信息

Burger Emily A, Jansen Erik E L, de Bondt Daniël, Killen James, Spencer Jennifer C, Regan Mary Caroline, Smith Megan A, Sy Stephen, Canfell Karen, de Kok Inge M C M, Kim Jane J, Hontelez Jan A C

机构信息

Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, MA 02115, United States.

Department of Health Management and Health Economics, University of Oslo, Oslo 0317, Norway.

出版信息

J Natl Cancer Inst. 2025 Jul 1;117(7):1498-1502. doi: 10.1093/jnci/djae319.

DOI:10.1093/jnci/djae319
PMID:39798139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12229461/
Abstract

Population-level estimates in time frames for reaching cervical cancer elimination (ie, <4 cases per 100 000 women) in the United States may mask potential disparities in achieving elimination among subpopulations. We used 3 independent Cancer Intervention and Surveillance Modeling Network models to estimate differences in the time to cervical cancer elimination across 7 strata of correlated screening and human papillomavirus vaccination uptake, based on national survey data. Compared with the average population, elimination was achieved at least 22 years earlier for the high-uptake strata and at least 27 years later for the most extreme low-uptake strata. Accounting for correlated uptake impacted the population average time frame by no more than 1 year. Consequently, national average elimination time frames mask substantial disparities in reaching elimination among subpopulations. Addressing inequalities in cervical cancer control could shorten elimination time frames and would ensure more equitable elimination across populations. Furthermore, country-level elimination monitoring could be supplemented by monitoring progress in subpopulations.

摘要

美国在实现消除宫颈癌(即每10万名女性中少于4例病例)的时间框架内进行的总体估计,可能掩盖了亚人群在实现消除方面的潜在差异。我们使用了3个独立的癌症干预和监测建模网络模型,根据全国调查数据,估计了在7个相关筛查和人乳头瘤病毒疫苗接种率分层中,实现消除宫颈癌所需时间的差异。与普通人群相比,高接种率分层至少提前22年实现消除,而最极端的低接种率分层则至少推迟27年。考虑相关接种率对总体平均时间框架的影响不超过1年。因此,全国平均消除时间框架掩盖了亚人群在实现消除方面的巨大差异。解决宫颈癌控制中的不平等问题可以缩短消除时间框架,并确保在人群中更公平地实现消除。此外,在国家层面进行消除监测的同时,可以补充对亚人群进展情况的监测。